Marijuana: Legality of DHHS claim Fed Reg July 8, 2011 Vol76 No131 21CFR Ch2 in contradiction to DHHS US Patent 6630507.

Federal Register Vol. 76 No. 131 Friday, July 8th 2011 Part IV, Department of Justice, Drug Enforcement Administration, 12 CFR Chapter 11 (Denial of Petition To Initiate Proceedings To Reschedule Marijuana; Proposed Rule). The US DHHS recommendation to the DEA is contradictory to US Patent 6630507 granted to the DHHS representing the US Government. Federal Register Vol. 76, No. 222 Thursday, November 17, 2011 / Notices 71351 DHHS NIH Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics To Treat Hepatic Encephalopathy in Humans gives exclusive rights, of patent 6630507, to KannaLife Sciences. Why is Marijuana still classified as a Schedule I narcotic under the CSA, Title II of the Drug Abuse Prevention and Control Act 21 USC 812(b)(1).